| Irubis–Ventura Biomed Investors: investment, 202210 seed financing round totalling €2.8m incl co-lead investor Ventura Biomed Investors |
2022-10-06 |
| Irubis–TU Munich: investment, 202210 seed financing round totalling €2.8m incl co-investor Initiative for Industrial Innovators |
2022-10-06 |
| Irubis–SEVERAL: investment, 202408 financing round pre-Series A led by new investor BioProcess360 Partners |
2024-08-29 |
| Irubis–SEVERAL: investment, 202210 seed financing round €2.8m led by HTGF + Verve Ventures + Ventura BioMed Investors |
2022-10-06 |
| Irubis–OTHER: investment, 202210 seed financing round totalling €2.8m incl business angels as co-investors |
2022-10-06 |
| Irubis–High-Tech Gründerfonds: investment, 202210 seed financing round totalling €2.8m incl co-lead investor HTGF |
2022-10-06 |
| Irubis–EU (govt): investment, 202210 seed financing round totalling €2.8m incl co-investor EIC Fund |
2022-10-06 |
| Irubis–EU (govt): grant, 202005– grant €1.3m from EIC Accelerator Pilot Programme |
2022-05-26 |
| Irubis–EU (govt): credit, 202203– convertible loan €500k from EIC Fund as part of EIC Accelerator Pilot programme |
2022-03-24 |
| IonSense–Covalent Bonds: public relations, 202106 service existent by Covalent Bonds |
2021-06-03 |
| IonSense–Bruker: investment, 202204 acquisition of IonSense by Bruker |
2022-04-06 |
| Ion Opticks–Adelis Equity Partners: investment, 202409 strategic investment by Adelis Equity Partners |
2024-09-10 |
| Interherence–Bruker: investment, 202307 acquisition $17.3m of Interherence GmbH by Bruker |
2023-07-03 |
| Integrated Proteomics Applications–Bruker: investment, 202009 acquisition €na of assets by Bruker |
2020-09-30 |
| Intabio–SEVERAL: investment, 201709 seed financing round $2m led by Jenny Rooke + incl Vertical Ventures + Morgan Noble + several individuals |
2017-09-14 |
| Intabio–Danaher: investment, 202101 acquisition $na of Intabio Inc by Sciex |
2021-01-21 |
| InstruNor–Fluidigm: investment, 202002 acquisition $7.2m with $5.2m in cash + $2m in stock |
2020-02-26 |
| Inscopix–Bruker: investment, 202211 acquisition $101.5m of Inscopix by Bruker |
2022-11-08 |
| Inivata–Soleus Capital: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + lead investor Soleus Capital |
2021-02-04 |
| Inivata–SEVERAL: investment, 202102 financing round Series C 2nd closing $35m led by Soleus Capital bringing total Series C to $60m |
2021-02-04 |
| Inivata–Janus Henderson: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + co-investor Janus Henderson Investors |
2021-02-04 |
| Inivata–IP Group: investment, 202102 financing round Series C 2nd closing totalling $35m incl existing + co-investor IP Group |
2021-02-04 |
| Inivata–Farallon Capital: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + co-investor Farallon Capital |
2021-02-04 |
| Infinitopes–SEVERAL: investment, 202404 seed financing round £12.8 (maybe incl non-dilutive Govt UK funding) led by Octopus Ventures |
2024-04-30 |
| InDevR–SEVERAL: investment, 202301 financing round Series B $9m from bioMérieux + Adjuvant Capital |
2023-01-17 |
| InDevR–Mérieux: investment, 202301 financing round Series B totalling $9m incl $5m from bioMérieux in connection w partnership |
2023-01-17 |
| InDevR–Adjuvant Capital: investment, 202301 financing round Series B totalling $9m incl $4m from Adjuvant Capital |
2023-01-17 |
| Impilo–SEVERAL: investment, 202412–202506 final closing at hard cap of €700m of Impilo Fund II |
2024-12-01 |
| Immunodiagnostic Systems–PerkinElmer: investment, 202105– recommended all cash offer £110m by PerkinElmer ANNOUNCED |
2021-05-17 |
| Immunocore–Danaher: data management software, 202409– supply Genedata SDMS for discovery of TCR therapeutics |
2024-09-05 |
| i3 Membrane–SEVERAL: investment, 202101 financing round 7-figure € sum from HTGF + three private investors |
2021-01-25 |
| i3 Membrane–OTHER: investment, 202101 financing round totalling 7-figure € sum incl three private investors |
2021-01-25 |
| i3 Membrane–High-Tech Gründerfonds: investment, 202101 financing round totalling 7-figure € sum inkl existing investor HTGF |
2021-01-25 |
| Hurel–Bico: investment, 202109 acquisition $2.5m of assets + operations of Hurel Corp + integration in Visikol |
2021-09-15 |
| Human Cell Design–Revvity: investment, 202609–acquisition €na of Human Cell Design by Revvity |
2026-09-09 |
| Horizon Discovery–PerkinElmer: investment, 202011– cash tender offer £296m ($383m) representing total enterprise value of £284m ($368m) |
2020-11-02 |
| HexagonFab–SEVERAL: investment, 202412 financing round Series A £6.6m of Abselion led by M Ventures |
2024-12-04 |
| HexagonFab–SEVERAL: investment, 202104 seed financing round £1.9m led by Cambridge Enterprise |
2021-04-20 |
| HexagonFab–Merck (DE): investment, 202412 financing round Series A totalling £6.6m of Abselion incl lead investor M Ventures |
2024-12-04 |
| Hema.to–SEVERAL: investment, 202306 seed financing round €3.6m with Elaia Partners + Heal Capital + HTGF |
2023-06-26 |
| Helmholtz–Bruker: NMR spectrometer, 202009c supply 1.2 GHz NMR spectrometer with 28 Tesla to FZ Jülich |
2020-09-01 |
| HEL Group–Zyme Communications: public relations, 202302 service existent by Zyme |
2023-02-08 |
| Halo Labs–Waters: investment, 202505 acquisiton of Halo Labs by Waters |
2025-05-21 |
| Gustave Roussy–Biognosys: MS-based proteomics, 202004– collab using proteomic profiling in attempt to repurpose tocilizumab for Covid-19 |
2020-04-28 |
| GSK–908 Devices: mass spectrometer, 202201 supply GSK purchases 5th Rebel CE-MS-based cell culture media analyser from 908 Devices |
2022-01-07 |
| GoSilico–Danaher: investment, 202106 acquisition of GoSilico GmbH by Cytiva |
2021-06-02 |
| Georgetown Univ–Fluidigm: mass cytometry, 202002– supply Hyperion Imaging System for new CoE for Imaging Mass Cytometry at GLCCC |
2020-02-10 |
| Genedata–Danaher: investment, 202408 acquisition of Genedata that will join Danaher’s Life Science segment |
2024-08-19 |
| Gene Company–Sphere Bio: cell analysis technology, 202504 distribution existent for Sphere Bio in China + Hong Kong by Gene Company |
2025-04-09 |
| Fluidigm–Viking Global Investors: investment, 202201–202204 acquisition totalling $250m zero-coupon convertible preferred shares incl Viking |
2022-01-24 |
| Fluidigm–SEVERAL: investment, 202201–202204 acquisition $250m zero-coupon convertible preferred shares by Casdin Capital + Viking Global Investors |
2022-01-24 |
| Fluidigm–Georgetown Univ: mass cytometry, 202002– collab establishment of joint CoE for Imaging Mass Cytometry at Georgetown Lombardi CCC |
2020-02-10 |
| Fluidigm–Casdin Capital: investment, 202201–202204 acquisition totalling $250m zero-coupon convertible preferred shares incl Casdin Capital |
2022-01-24 |
| Fasmatech–Bruker: investment, 202303 acquisition $10.3m of Fasmatech by Bruker |
2023-03-03 |
| Exum Instruments–TOFwerk: Massbox, 2018– TOFwerk + ESI join as equity partners to design + produce first instrument |
2018-01-01 |
| Exum Instruments–TOFwerk: investment, 2018 TOFwerk + ESI join as equity partners to design + produce first instrument |
2018-01-01 |
| Exum Instruments–SEVERAL: investment, 2019 seed financing round |
2019-01-01 |
| Exum Instruments–Free Radical Ventures: investment, 2018 early investment by Free Radical Ventures |
2018-01-01 |
| Exum Instruments–Elemental Scientific: Massbox, 2018– TOFwerk + ESI join as equity partners to design + produce first instrument |
2018-01-01 |
| Exum Instruments–Elemental Scientific: investment, 2018 TOFwerk + ESI join as equity partners to design + produce first instrument |
2018-01-01 |
| Exelead–Merck (DE): investment, 202201 acquisition $760m in cash by Merck |
2022-01-06 |
| Excellims–Covalent Bonds: public relations, 202107 service existent by Covalent Bonds |
2021-07-21 |
| Exact Sciences–Abbott: investment, 202511– acquisition $21b via cash tender offer at $105/share ANNOUNCED |
2025-11-20 |
| Evotec–Biognosys: MS-based proteomics, 202109– collab integration of Spectronaut proteomics data analys into drug discovery + clinical proteomics |
2021-09-14 |
| Evosep–Novo Group: investment, 202301 minority investment of $40m by Novo Holdings A/S |
2023-01-09 |
| Evosep–Nordic Capital: investment, 202511 investment €na making Nordic Capital majority shareholder of Evosep |
2025-11-18 |
| Everlife Research Instruments–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in Singapore by Everlife |
2025-04-09 |
| Eurofins–Waters: mass spectrometer, 202011 supply existent Radian ASAP System beta customer Eurofins Forenscis Teddington |
2020-11-02 |
| Envue Technologies–NanoTemper: investment, 202511 acquisition of Envue by NanoTemper |
2025-11-05 |
| Endress+Hauser–Roboscreen: investment, 202006 management buy-out of Roboscreen GmbH from Analytik Jena AG Group |
2020-06-01 |
| Enantios–SEVERAL: investment, 202407 seed financing round >CHF1.8m led by Privilège Ventures |
2024-07-01 |
| Enable Medicine–SEVERAL: investment, 202204 financing round Series A $60m led by Anthos Capital + General Catalyst |
2022-04-07 |
| Enable Medicine–KKH Advisors: public relations, 202402 service existent by KKH Advisors |
2024-02-13 |
| Emphysys–Paramit: investment, 202011 acquisition of Emphysis Inc by Paramit Corp |
2020-11-24 |
| EMC Industrial Group (NZ)–Endress+Hauser: investment, 202511 acquisition of process measurement business of EMC + integration into EH New Zealand |
2025-11-01 |
| Ellab–Novo Group: investment, 202306– acquisition of Ellab by Novo Holdings from EQT Private Equity + co-shareholders |
2023-06-21 |
| Ellab–EQT: investment, 201908–201909 acquisition €na majority share by EQT Mid Market Europe Fund from IK VIII Fund |
2019-08-07 |
| Elitech–PAI Partners: investment, 201705– acquisition of Elitech Group by PAI Partners from Ergon Capital Partners |
2017-05-11 |
| Elitech–Bruker: investment, 202312– acquisition €870m in cash of Elitech Group from PAI Partners SIGNED Put Option Letter |
2023-12-23 |
| Elemental Machines–SEVERAL: investment, 202211 financing round Series B $41m led by Sageview Capital |
2022-11-10 |
| EasyPanel–Dotmatics: investment, 202407 acquisition of EasyPanel by Dotmatics |
2024-07-30 |
| e-MSion–Agilent: investment, 202303 acquisition of e-MSion by Agilent |
2023-03-09 |
| Dynamic Biosensors–Bruker: investment, 202410 acquisition €na of Dynamic Biosensors GmbH + integration in Bruker Biosensors business |
2024-10-02 |
| Dotmatics–Siemens: investment, 202502–202507 acquisition $5.1b of Dotmatics from Insight Partners |
2025-04-02 |
| DNTox–SEVERAL: investment, 202306 seed financing round €1.4m led by HTGF |
2023-06-14 |
| DNA Script–SEVERAL: investment, 202110 financing round Series C $165m co-led by Coatue Management + Catalio Capital Management |
2021-10-26 |
| DNA Script–SEVERAL: investment, 202007 financing round Series B extension $50m led by Casdin Capital |
2020-07-29 |
| DNA Script–Danaher: investment, 202110 financing round Series C totalling $165m incl existing + co-investor Danaher Life Sciences |
2021-10-26 |
| DNA Script–Agilent: investment, 202110 financing round Series C totalling $165m incl existing + co-investor Agilent Technologies |
2021-10-26 |
| Distributed Bio–Charles River: investment, 202012 acquisition $83m upfront cash + $21m milestones |
2020-12-31 |
| Discover Echo–Cellink: investment, 202106– acquisition $110m with $98m in cash + $12m in new Series B shares ANNOUNCED |
2021-06-26 |
| Delta Precision–Astrea Bioseparations: investment, 202301 acquisition of Delta Precision Ltd by Astrea |
2023-01-09 |
| DeepEn–Thuringia (govt): investment, 202502 seed financing round totalling € 7-digit incl investor bm|t |
2025-02-17 |
| DeepEn–Sparkassen (DE): investment, 202502 seed financing round totalling € 7-digit incl investor Sparkasse Jena-Saale-Holzland |
2025-02-17 |
| DeepEn–SEVERAL: investment, 202502 seed financing round € 7-digit from bm|t + MBG Thüringen + Sparkasse-Jena-Holzland |
2025-02-17 |
| DeepEn–MBG Thüringen: investment, 202502 seed financing round totalling € 7-digit incl investor MBG Thüringen |
2025-02-17 |
| Decode Science–Sphere Bio: cell analysis technology, 202504– distribution for Sphere Bio in Australia + New Zealand by Decode Science |
2025-04-09 |
| Debiopharm–Dotmatics: data integration + analysis s/w, 202204 supply existent Debiopharm is customer of Dotmatics |
2022-04-26 |
| De Novo Software–Insightful Science: investment, 202109 acquisition of De Novo Software by Insightful Science |
2021-09-14 |
| Day Zero Diagnostics–Mérieux: investment, 202506 acquisition <$25m of assets of Day Zero Diagnostics by bioMérieux |
2025-06-16 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
1 2 3 4 5 6 
Deal: Collaboration or Financing
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
